Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

335
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
335
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

66
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
66
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Drug Regulation01:25

Drug Regulation

3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empathetic and Emotive Design Heuristics for Social Robots.

Studies in health technology and informatics·2026
Same author

Use and Usability of Wearable Devices in Assistive Living: A Scoping Review.

Studies in health technology and informatics·2026
Same author

Think-Reflect LLM: A Multi-Method Approach to Using Think Aloud Protocol Analysis and Prompted Reflections to Understand LLM Use.

Studies in health technology and informatics·2026
Same author

Educational and Research Uses for Smart Home and Mobile Health Technologies to Ensure Their Safety and Usability.

Studies in health technology and informatics·2026
Same author

Building Relationships: A Scoping Review of Empathy in Human-Robot Interaction.

Studies in health technology and informatics·2026
Same author

Advances and Trends in Clinical Information Systems: From AI to Machine Learning Applications and Beyond.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: Mar 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

All Consumer Medication Information Is Not Created Equal: Implications for Medication Safety.

Helen Monkman1, Andre W Kushniruk1

  • 1School of Health Information Science, University of Victoria, Victoria, BC.

Studies in Health Technology and Informatics
|February 11, 2017
PubMed
Summary

Consumer medication information (CMI) in Canada lacks critical safety details like allergic reactions and drug interactions. Enhancements are needed to ensure safe and effective prescription medication use for Canadians.

Keywords:
consumer medication informationmedicationpatient educationpatient medication informationpharmacyprescriptionreadability

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Related Experiment Videos

Last Updated: Mar 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Area of Science:

  • Health Sciences
  • Pharmaceutical Sciences
  • Patient Safety

Background:

  • Millions of Canadians rely on prescription medications, necessitating clear guidance for safe and effective use.
  • Proper administration of certain medications, such as inhalers and eye drops, is crucial for maximizing therapeutic benefits.
  • Existing Consumer Medication Information (CMI) plays a vital role in educating patients about their prescriptions.

Purpose of the Study:

  • To evaluate the content and clarity of Consumer Medication Information (CMI) provided by a leading Canadian pharmacy.
  • To identify deficiencies in CMI regarding essential safety information and administration instructions.
  • To explore opportunities for improving CMI to enhance patient safety and medication efficacy.

Main Methods:

  • A qualitative analysis of 10 Consumer Medication Information (CMI) documents from a prominent Canadian pharmacy.
  • Assessment of CMI for the presence of information on allergic reactions, overdoses, and drug interactions.
  • Evaluation of the readability and distinctiveness of critical information within the CMI documents.
  • Specific review of administration instructions for various medication types, including inhalers.

Main Results:

  • None of the 10 reviewed CMI documents included information on allergic reactions, overdoses, or drug interactions.
  • Critical safety information was often not easily distinguishable from surrounding text.
  • Inhaler medications lacked specific use instructions, directing consumers to external resources.
  • Significant gaps were identified in providing comprehensive guidance for medication use.

Conclusions:

  • Current Consumer Medication Information (CMI) in Canada has critical omissions regarding medication safety and administration.
  • These deficiencies pose a potential risk to patient safety and the effective use of prescription drugs.
  • There are significant opportunities to improve CMI, both in its current printed format and in emerging online platforms, to better support Canadians in managing their medications.